FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews
In Brief: Walter Lawrence, Reginald Ho Lead ACS; Henderson To Leave Dana-Farber for UCSF
NCI To Fund More Than 1,000 Competing Grants Under FY 1992 Budget
FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available
DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation
DCE Technical Support Contracts Recompetition Approved in Concept
Trending Stories
- “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process - DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
- How City of Hope is turning microbiome science into better cancer care
- Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.”









